Yokukansan and its ingredients as possible treatment options for schizophrenia
Chuan-Hsun Yu,1 Ryouhei Ishii,2 Shun-Chieh Yu,1 Masatoshi Takeda2 1Yuli Hospital, Department of Health, Hualien, Taiwan; 2Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan Abstract: Schizophrenia is a debilitating psychotic mental disorder that affects almost th...
Guardado en:
Autores principales: | Yu CH, Ishii R, Yu SC, Takeda M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fcda9a1a0f674ee1bcb444de8773ba05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lack of tolerable treatment options for patients with schizophrenia
por: Citrome L, et al.
Publicado: (2015) -
Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang L, et al.
Publicado: (2014) -
Posttraumatic epilepsy: current and emerging treatment options
por: Paiva WS, et al.
Publicado: (2014) -
Narcolepsy: current treatment options and future approaches
por: Michel Billiard
Publicado: (2008) -
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari J, et al.
Publicado: (2013)